CELC
USDCelcuity Inc. Common Stock
Preço em tempo real
Gráfico de preços
Métricas-chave
Métricas de mercado
Abertura
$12.320
Máximo
$12.770
Mínimo
$12.320
Volume
0.13M
Fundamentos da empresa
Capitalização de mercado
476.0M
Setor
Biotecnologia
País
United States
Estatísticas de negociação
Volume médio
0.23M
Bolsa de valores
NCM
Moeda
USD
Faixa de 52 semanas
Notícias relacionadas
HC Wainwright & Co. Reiterates Buy on Celcuity, Maintains $27 Price Target
HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Celcuity with a Buy and maintains $27 price target.
Needham Reiterates Buy on Celcuity, Maintains $29 Price Target
Needham analyst Gil Blum reiterates Celcuity with a Buy and maintains $29 price target.
Celcuity Inc. Reports First Quarter 2025 Financial Results and Provides Corporate Update
The primary completion date of the PIK3CA wild-type cohort of the VIKTORIA-1 Phase 3 trial is expected in June 2025 and a topline data readout is anticipated in the third quarter of 2025 Enrollment is ongoing in the
Celcuity Inc. Schedules Release of First Quarter 2025 Financial Results and Webcast/Conference Call
MINNEAPOLIS, May 07, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that it will release its
Ações relacionadas
Mantenha-se atualizado
Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.